Sarah Eternal SRL fined €900,000 by Dutch regulator 11 March 2025 Steve Tyler Leave a comment 🔒This article requires Free Subscription.Upgrade Now
KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma 28 April 2025
